Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Takara Bio expands custom enzyme manufacturing capability in Sweden
, /in E-News /by panglobalTakara Bio Europe has expanded its Gothenburg facility with a new custom manufacturing laboratory, significantly boosting its capacity to produce molecular biology reagents for the EMEA region. The facility, which became operational on 1 October 2024, is capable of manufacturing up to 600,000 reactions weekly, addressing the growing demands of academic research institutions, diagnostic laboratories, […]
Cellular Origins and Fresenius Kabi collaborate on automated cell therapy manufacturing
, /in E-News /by panglobalPartnership focuses on Cue system integration
New service aims to revolutionise clinical trial data submissions
, /in E-News /by panglobalSGS, the global testing and certification organisation, has unveiled a specialised consultancy service focused on transforming the complex process of clinical trial data submissions. The CDISC Open Rules Consultancy aims to address the increasingly intricate requirements of regulatory compliance in clinical research.
Sapio Sciences expands AWS collaboration to enhance science-aware AI capabilities
, /in E-News /by panglobalThe laboratory informatics company Sapio Sciences has announced a significant expansion of its partnership with Amazon Web Services (AWS), marking a potential watershed moment in the application of artificial intelligence to drug discovery and development workflows.
GenNext and Agilent combine technologies to enhance structural biology analysis
, /in E-News /by panglobalA novel integration of protein footprinting and ion mobility mass spectrometry technologies promises to accelerate structural biology research in the biopharmaceutical sector, following a collaboration announced by GenNext Technologies and Agilent.
Antiverse secures £3.5m to advance AI-driven antibody design platform
, /in E-News /by panglobalThe Cardiff-based antibody design company Antiverse has secured £3.5 million in additional seed funding, bringing their total equity financing to £7.2 million. The investment round, spearheaded by i&i Biotech Fund I and Kadmos Capital, saw participation from existing investors including InnoSpark Ventures, UKI2S, Tensor Ventures, and AngelHub.
Hoxb8 MAT improves diagnosis of peanut allergy
, /in Featured Articles, Autoimmunity & Allergy /by panglobalA recent report published by the Food Standards Agency in the UK [Patterns and prevalence of adult food allergy (PAFA); https://shorturl.at/jnaLY] estimates that around 6% of the UK adult population have a clinically confirmed IgE-mediated food allergy.
Weighted analysis of autoantibodies in new classification criteria for antiphospholipid syndrome
, /in Featured Articles, Autoimmunity & Allergy /by panglobalBy Dr Jacqueline Gosink New American College of Rheumatology and European Alliance of Associations for Rheumatology classification criteria for antiphospholipid syndrome have been developed to aid cohort selection for research and clinical trials. The classification system includes both clinical and laboratory criteria, which are hierarchically clustered, weighted and risk-stratified to ensure high specificity.
Causes of congenital neutropenia and challenges of diagnosis
, /in Hematology & Flow Cytometry, Featured Articles /by panglobalThe congenital neutropenia syndromes are rare conditions caused by mutations in genes associated with various cell processes. While their clinical presentations may overlap, their natural histories vary. Accurate diagnosis of the genetic etiology of specific conditions is crucial for providing individually tailored management, as the different syndromes have different risk profiles for progression to bone […]
Mapping, monitoring and surveillance of Tropical and Neglected Diseases
, /in Featured Articles, Rapid Tests & POC /by panglobalTropical infectious diseases such as malaria, cholera, yellow fever, and Dengue affect more than 2 billion people worldwide. Also included in this list are the so-called “Neglected Tropical Diseases” or NTD’s, a sub-group of mainly infectious diseases that occur against a background of extreme poverty. The WHO lists 17 priority Neglected Tropical Diseases, among them […]